Considering the different ANKRD29 expression in immune subtypes of LUAD and LUSC, we analyzed the expression of ANKRD29 in different cell types of NSCLC from TISCH2, a published single-cell RNA sequencing dataset [31], and found that ANKRD29 predominantly expressed in malignant tumor cells (Fig. S4C, D). This evidence concerns the gene ANKRD29 and cancer.